Roche invests $50B to expand pharmaceutical and diagnostics manufacturing facilities in multiple U.S. states
Roche has announced plans to expand its manufacturing and research footprint across several cities and states in the U.S. The company, which produces pharmaceuticals and diagnostics, is investing $50 billion into the project and creating more than 12,000 new jobs, including nearly 6,500 construction roles and 1,000 positions at new and expanded facilities.
The investment will support a wide range of facility developments and enhancements, including expanded and upgraded manufacturing and distribution capabilities in Kentucky, Indiana, New Jersey, Oregon, and California. In Pennsylvania, Roche will build a new gene therapy manufacturing facility. The company also plans to construct a new 900,000-square-foot manufacturing center to support its portfolio of weight loss medicines, with the exact location to be announced.
In Indiana, Roche will establish a new facility dedicated to continuous glucose monitoring. Massachusetts will be home to a new R&D center focused on artificial intelligence research and cardiovascular, renal, and metabolism-related developments. Roche will also significantly expand and upgrade existing R&D sites in Arizona, Indiana, and California.
What people are saying
In a recent quote, Thomas Schinecker, Group CEO, Roche, said, “Roche is a Swiss company with a strong heritage in more than 130 countries globally. Today’s announced investments underscore our long-standing commitment to research, development and manufacturing in the US. We are proud of our 110 year legacy in the United States which has been a key driver for jobs, innovation and the creation of intellectual property in the US, across both our Pharmaceutical and Diagnostics Divisions. Our investments of USD 50 billion over the next five years will lay the foundation for our next era of innovation and growth, benefiting patients in the US and around the world.”
Investing in American manufacturing in 2025
This map shows where manufacturers are choosing to invest their resources, whether they are building new production facilities or expanding existing plants.
About the Author
Alexis GajewskiAlexis Gajewski
Senior Content Strategist
Alexis Gajewski is a manufacturing writer and editor with nearly 20 years of experience covering the people, practices, and technologies that keep industrial facilities running. For more than a decade, she served as Senior Content Strategist for Plant Services, creating content for plant managers, engineers, and maintenance professionals on a variety of industrial topics.
During her tenure, Alexis worked to develop the brand’s digital strategy and helped launch and produce Great Question: A Manufacturing Podcast. She also created The Lighter Side of Manufacturing, a weekly blog that explored the inventive and sometimes humorous side of the industry.
Alexis co-founded Influential Women in Manufacturing, a recognition program that honored 49 women in its first two years, earned an industry award for Best Product Launch, and received a proclamation from Illinois Governor JB Pritzker and a commendation from U.S. Senator Tammy Duckworth.
She also led newsroom operations and development at a large media company where she set editorial standards, developed training curriculum, and helped support AI adoption for more than 150 editors across 80+ brands spanning manufacturing, industrial processing, automation, and more.
Additionally, Alexis works as a freelance writer and editor, and her areas of interest include continuous improvement, the skilled workforce, and the role of emerging technology on the plant floor.
Connect with Alexis on LinkedIn